Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Progesterone vs 17-OHPC in Placenta Previa
NCT03779451Unknown
- Sponsor
- Aswan University Hospital
- Start
- Jan 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of progesterone and hydroxyprogesterone caproate in placenta previa (3 arms), sponsored by Aswan University Hospital. Primary endpoint: Number of patients delivered before 37 weeks at 2 months. Status: unknown.
02
Drugs
progesteronehydroxyprogesterone caproate
03
Conditions
placenta previa
Beyond the preview
Go deeper on NCT03779451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03779451.